Barclays
TWST icon

Barclays’s Twist Bioscience TWST Stock Holding History

Barclays’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-60,000
Closed -$2.06M – 5305
2024
Q1 		$2.06M Buy
+60,000
New +$2.17M ﹤0.01% 2548

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Barclays's TWST Position: Q2 2026 in Review

Barclays increased its Twist Bioscience (TWST) stake by 252% in Q2 2026, buying an estimated $1.86M and bringing the position to 39,944 shares worth $4.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1947.

Barclays first reported a position in TWST in Q4 2018 and has held it in 31 quarters since. The position peaked at $13M in Q2 2023. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Barclays held 39,944 shares of Twist Bioscience worth $4.11M as of Q2 2026.
  • Barclays bought 28,585 Twist Bioscience shares in Q2 2026, an estimated $1.86M.
  • Twist Bioscience made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1947 holding.
  • Barclays first reported a position in Twist Bioscience in Q4 2018 and has held it in 31 quarters since.
  • Barclays's Twist Bioscience position peaked at $13M in Q2 2023.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.